Opioid use disorder (OUD) is a public health crisis in America. Pharmacotherapy treatment of OUD is associated with improved outcomes and has been steadily increasing over recent years. Buprenorphine is one of the most common medications prescribed for OUD and has several pharmacologic advantages over methadone for OUD. However, many clinicians are concerned about its unique pharmacokinetic profile in the perioperative setting where acute pain is expected. Many clinicians lack the sufficient tra...